mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.009 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |